PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

Go back to PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
(NASDAQ: BNTC) Delayed: 13.63 --0 (-0%)
Previous Close $13.63    52 Week High $5.64 
Open $13.63    52 Week Low $1.20 
Day High $13.63    P/E N/A 
Day Low $13.63    EPS $0.00 
Volume 22       

(NASDAQ: PRTC) Delayed: 17.42 --0 (-0%)
Previous Close $17.42    52 Week High
Open $17.42    52 Week Low
Day High $17.42    P/E N/A 
Day Low $17.42    EPS
Volume 7,198       

(NASDAQ: PRTC) Delayed: 17.42 --0 (-0%)
Previous Close $17.42    52 Week High
Open $17.42    52 Week Low
Day High $17.42    P/E N/A 
Day Low $17.42    EPS
Volume 7,198